What is the Brooks Laboratories Ltd share price today?

The share price of NSE:BROOKS-EQ on 07 Sep 2026 (as of 10:58:59 IST) is ₹67.50.

What is the NSE:BROOKS-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:BROOKS-EQ 52 week high low range shows a high of ₹163.90 and a low of ₹36.30.

What is the Brooks Laboratories Ltd market cap?

As on 07 Sep 2026, Brooks Laboratories Ltd market cap is ₹194.21 Cr.

What is the shareholding pattern of Brooks Laboratories Ltd Stock?

The shareholding pattern of Brooks Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 52.62% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 9.90% Retail & Others: 37.48% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Brooks Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Brooks Laboratories Ltd is 14.70, and the Price-to-Book (PB) ratio is 0.90, as on 07 Sep 2026.

Brooks Laboratories Share Price

59.09-2.44 (-3.97%)

-60.44% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-3.97%

1 Week

-3.16%

1 Month

-1.52%

3 Month

-19.62%

6 Month

+26.31%

YTD

-26.27%

1 Year

-60.44%

5 Year

-56.15%

10 Year

-49.51%

Max

-40.34%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

59.00

58.22

57.50

36.30

High

63.80

63.89

71.40

79.69

79.70

153.99

About

Brooks Laboratories Limited (Brooks Laboratories) is a pharmaceutical contract research and manufacturing services company. It provides range of products catering to critical care segment in Parental Section, such as Beta Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

AUROPHARMANSE

LUPINNSE

DRREDDYNSE

MANKINDNSE

BROOKSNSE

LTP

1W Low

1W High

Market cap (₹)

1868.9+15.4 (0.83%)

1832.20

1891.50

4,40,398Cr

9410.5+252.5 (2.76%)

9135.50

9461.50

2,48,664Cr

4970+157.5 (3.27%)

4794.50

4986.50

1,82,738Cr

1161+53.5 (4.83%)

1100.10

1173.50

1,15,012Cr

1386.1+28.1 (2.07%)

1351.60

1405.20

1,10,794Cr

2017.5+112 (5.88%)

1894.80

2023.50

1,05,645Cr

1713.4+70.4 (4.28%)

1634

1738.90

99,828Cr

2124.5+79.5 (3.89%)

2046.30

2129

98,070Cr

1198.3+58.3 (5.11%)

1140

1211.90

97,749Cr

2437.8+191.8 (8.54%)

2242.10

2452

95,744Cr

59.09-1.93 (-3.16%)

58.22

63.89

181Cr

Brooks Laboratories Share Price

59.09-2.44 (-3.97%)

-60.44% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years2%

3 years11%

Last year4%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year347%

Stock Price CAGR

10 years-7%

5 years-15%

3 years-15%

1 year-60%

Return on Equity

10 years-17%

5 years-16%

3 years-6%

Last year22%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	2%	11%	4%
-	-	-	347%
-7%	-15%	-15%	-60%
-17%	-16%	-6%	22%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

AUROPHARMA

LUPIN

DRREDDY

MANKIND

BROOKS

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,868.9	₹440398 Cr	36.41	12.07	62.82	₹11479 Cr
9,410.5	₹248664 Cr	85.01	34.04	128.41	₹2568 Cr
4,970	₹182738 Cr	83.79	16.72	97.06	₹2163 Cr
1,161	₹115012 Cr	25.48	9.42	62.53	₹5040 Cr
1,386.1	₹110794 Cr	32.87	9.77	57.87	₹3879 Cr
2,017.5	₹105645 Cr	96.62	6.8	29.25	₹889 Cr
1,713.4	₹99828 Cr	26.89	17.95	96.84	₹3505 Cr
2,124.5	₹98070 Cr	17.74	30.95	154.36	₹5333 Cr
1,198.3	₹97749 Cr	30.34	5.32	63.99	₹4196 Cr
2,437.8	₹95744 Cr	46.87	13.75	71.08	₹1913 Cr
59.09	₹181 Cr	13.69	-0.61	5.03	₹25 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020
₹23 Cr	₹20 Cr	₹17 Cr	₹23 Cr	₹26 Cr	₹23 Cr	₹21 Cr	₹21 Cr	₹18 Cr	₹18 Cr	₹22 Cr	₹24 Cr	₹16 Cr	₹13 Cr	₹15 Cr	₹18 Cr	₹17 Cr	₹28 Cr	₹19 Cr	₹21 Cr	₹22 Cr	₹15 Cr	₹21 Cr	₹29 Cr
₹18 L	₹44 L	₹13 L	₹39 L	₹22 L	₹62 L	₹3 L	₹20 L	₹7 L	₹65 L	₹16 L	₹9 L	₹6 L	₹3 L	₹9 L	₹14 L	₹3 L	₹18 L	₹37 L	₹56 L	₹70 L	₹6 L	₹4 L	₹52 L
₹23 Cr	₹21 Cr	₹17 Cr	₹24 Cr	₹26 Cr	₹24 Cr	₹21 Cr	₹21 Cr	₹18 Cr	₹18 Cr	₹22 Cr	₹24 Cr	₹16 Cr	₹13 Cr	₹15 Cr	₹18 Cr	₹17 Cr	₹29 Cr	₹19 Cr	₹22 Cr	₹22 Cr	₹15 Cr	₹21 Cr	₹30 Cr
₹22 Cr	₹20 Cr	₹16 Cr	₹21 Cr	₹23 Cr	₹22 Cr	₹19 Cr	₹20 Cr	₹18 Cr	₹18 Cr	₹21 Cr	₹23 Cr	₹16 Cr	₹13 Cr	₹26 Cr	₹30 Cr	₹28 Cr	₹34 Cr	₹27 Cr	₹27 Cr	₹24 Cr	₹20 Cr	₹23 Cr	₹26 Cr
₹2 Cr	₹1 Cr	₹86 L	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹35 L	₹1 Cr	₹1 Cr	₹2 Cr	₹8 L	-₹9 L	-₹8 Cr	-₹9 Cr	-₹9 Cr	-₹4 Cr	-₹6 Cr	-₹4 Cr	₹33 L	-₹4 Cr	-₹62 L	₹6 Cr
₹21 L	₹9 L	₹16 L	₹28 L	₹30 L	₹26 L	₹28 L	₹32 L	₹16 L	₹27 L	₹21 L	₹19 L	₹17 L	₹18 L	₹75 L	₹63 L	₹62 L	₹84 L	₹74 L	₹75 L	₹76 L	₹74 L	₹78 L	₹80 L
₹1 Cr	₹61 L	₹30 L	₹2 Cr	₹3 Cr	₹2 Cr	₹94 L	₹96 L	-₹21 L	₹30 L	₹60 L	₹1 Cr	-₹53 L	-₹71 L	-₹11 Cr	-₹12 Cr	-₹11 Cr	-₹7 Cr	-₹9 Cr	-₹7 Cr	-₹2 Cr	-₹6 Cr	-₹3 Cr	₹3 Cr
₹1 Cr	₹61 L	₹30 L	₹2 Cr	₹3 Cr	₹1 Cr	₹94 L	₹96 L	-₹21 L	₹30 L	₹58 L	₹1 Cr	-₹53 L	-₹71 L	-₹9 Cr	-₹8 Cr	-₹9 Cr	-₹6 Cr	-₹7 Cr	-₹5 Cr	-₹1 Cr	-₹17 Cr	-₹3 Cr	₹3 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
—	—	—	—	—	—
₹29 Cr	₹29 Cr	₹26 Cr	₹25 Cr	₹25 Cr	₹25 Cr
₹93 Cr	₹69 Cr	₹39 Cr	₹49 Cr	₹63 Cr	₹54 Cr
₹93 Cr	₹69 Cr	₹39 Cr	₹49 Cr	₹63 Cr	₹54 Cr
₹123 Cr	₹98 Cr	₹66 Cr	₹74 Cr	₹87 Cr	₹79 Cr
₹0	₹0	₹0	₹0	₹47 Cr	₹0
₹1 Cr	₹13 L	₹0	₹0	₹9 Cr	₹14 Cr
₹0	₹0	₹0	₹0	-₹1 Cr	₹3 Cr
₹1 Cr	₹2 Cr	₹89 L	₹1 Cr	₹1 Cr	₹10 L
₹1 Cr	₹88 L	₹93 L	₹1 Cr	₹2 Cr	₹2 Cr
₹4 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹11 Cr	₹19 Cr
—	—	—	—	—	—
₹11 Cr	₹14 Cr	₹15 Cr	₹23 Cr	₹28 Cr	₹31 Cr
₹3 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹9 Cr	₹18 Cr
₹6 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹11 Cr	₹14 Cr
₹1 Cr	₹95 L	₹64 L	₹1 Cr	₹1 Cr	₹1 Cr
₹22 Cr	₹23 Cr	₹23 Cr	₹33 Cr	₹49 Cr	₹64 Cr
₹148 Cr	₹124 Cr	₹90 Cr	₹110 Cr	₹195 Cr	₹162 Cr
₹123 Cr	₹76 Cr	₹71 Cr	₹20 Cr	₹24 Cr	₹7 Cr
₹7 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹24 Cr	₹31 Cr
—	—	—	—	—	—
₹26 Cr	₹25 Cr	₹23 Cr	₹23 Cr	₹143 Cr	₹133 Cr
₹11 Cr	₹11 Cr	₹10 Cr	₹8 Cr	₹33 Cr	₹26 Cr
₹15 Cr	₹14 Cr	₹14 Cr	₹15 Cr	₹110 Cr	₹108 Cr
₹1 Cr	₹0	₹0	₹0	₹15 Cr	₹68 L
₹92 Cr	₹74 Cr	₹43 Cr	₹64 Cr	₹6 L	₹2 L
₹92 Cr	₹74 Cr	₹43 Cr	₹64 Cr	₹6 L	₹2 L
₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹8 Cr	₹3 Cr
₹14 L	₹9 L	₹13 L	₹17 L	₹22 L	₹31 L
₹111 Cr	₹90 Cr	₹59 Cr	₹82 Cr	₹133 Cr	₹112 Cr
—	—	—	—	—	—
₹11 Cr	₹9 Cr	₹10 Cr	₹11 Cr	₹28 Cr	₹24 Cr
₹16 Cr	₹20 Cr	₹16 Cr	₹13 Cr	₹18 Cr	₹14 Cr
₹8 Cr	₹1 Cr	₹69 L	₹1 Cr	₹4 Cr	₹2 Cr
₹53 L	₹1 Cr	₹2 Cr	₹40 L	₹2 Cr	₹65 L
₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹11 Cr	₹8 Cr
₹37 Cr	₹34 Cr	₹31 Cr	₹28 Cr	₹61 Cr	₹47 Cr
₹16 Cr	₹11 Cr	₹8 Cr	-₹5 Cr	₹12 Cr	-₹16 Cr
₹148 Cr	₹124 Cr	₹90 Cr	₹110 Cr	₹195 Cr	₹162 Cr
₹42	₹33	₹25	₹30	₹35	₹32
₹42	₹33	₹25	₹30	₹35	₹32

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
₹25 Cr	-₹10 Cr	-₹20 Cr	-₹38 Cr	-₹24 Cr	-₹9 Cr
-₹17 Cr	₹14 Cr	₹23 Cr	₹13 Cr	₹11 Cr	₹10 Cr
₹2 Cr	-₹3 Cr	-₹13 Cr	₹11 Cr	-₹24 Cr	₹7 Cr
₹9 Cr	₹2 Cr	-₹10 Cr	-₹14 Cr	-₹37 Cr	₹9 Cr
₹9 Cr	₹3 Cr	-₹10 Cr	-₹14 Cr	-₹37 Cr	₹4 Cr
-₹3 Cr	-₹45 Cr	₹18 L	₹49 L	-₹25 Cr	-₹5 Cr
₹17 L	₹42 Cr	₹10 Cr	₹11 Cr	₹64 Cr	₹1 Cr
₹7 Cr	-₹8 L	₹10 L	-₹3 Cr	₹2 Cr	₹49 L
₹4 L	₹13 L	₹2 L	₹3 Cr	₹88 L	₹40 L
₹7 Cr	₹4 L	₹13 L	₹2 L	₹3 Cr	₹88 L

Fundamental Ratios

Consolidated

Standalone

No results found

Brooks Laboratories Share Price

59.09-2.44 (-3.97%)

-60.44% past 1 Year

Shareholding summary

Promoters

52.62%

FII

DII

9.9%

Others

37.48%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
52.62%	52.62%	52.62%	52.62%	52.62%	52.62%
0.00%	0.17%	0.09%	0.01%	0.00%	0.05%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
9.90%	9.90%	9.90%	9.90%	9.90%	9.90%
37.48%	37.31%	37.39%	37.47%	37.48%	37.43%

Bulk & block deals

Name

Ramesh Thakurdas Jaisinghani

One Up Financial Consultants Pvt Ltd

Rr Family Trust

Aryan Mahajan

Atul Ranchal

Saravana Global Holdings Limited

Mukul Maheshwari (Huf)

Guttikonda Rajasekhar

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
08 May 2026	Sell	86.34 L	₹50.55	1.71 L	Bulk	0.579834	NSE
14 Nov 2024	Purchase	5.46 Cr	₹136.40	4 L	Bulk	1.357902	NSE
14 Nov 2024	Purchase	3 Cr	₹137.40	2.18 L	Bulk	0.741075	BSE
14 Nov 2024	Sell	6.60 Cr	₹137.40	4.80 L	Bulk	1.629483	BSE
14 Nov 2024	Sell	5.39 Cr	₹136.40	3.95 L	Bulk	1.340966	NSE
14 Nov 2024	Sell	2.75 Cr	₹137.40	2 L	Bulk	0.678951	BSE
16 May 2024	Sell	1.27 Cr	₹92.12	1.38 L	Bulk	0.469827	NSE
21 Apr 2022	Purchase	1.38 Cr	₹104.67	1.32 L	Bulk	0.44694	NSE
21 Apr 2022	Sell	40.28 L	₹104.83	38.42 K	Bulk	0.130437	NSE
03 Mar 2022	Purchase	1.43 Cr	₹89.25	1.60 L	Bulk	0.543443	NSE

Insider trading & SAST

Client name

Aryan Mahajan

Atul Ranchal & Pacs

Saras Gupta

Atul Ranchal

Saras Gupta

Atul Ranchal

Aryan Mahajan

Davinder Kumari (Revised)

Erwin Mahajan

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
22 Nov 2024	Promoter	Disposal	1.83	2.77	0	—	4.80 L	14 Nov 2024	Market	7,26,490	SAST	29(2)	—
22 Nov 2024	Promoter	Disposal	4.54	59.06	0	—	11.90 L	14 Nov 2024	Market	1,55,00,292	SAST	29(2)	—
22 Nov 2024	Promoter	Disposal	0.44	2.63	0	—	1.15 L	14 Nov 2024	Market	6,90,143	SAST	29(2)	—
22 Nov 2024	Promoter	Disposal	2.27	21.6	0	—	5.95 L	14 Nov 2024	Market	56,68,060	SAST	29(2)	—
17 Nov 2024	Promoter	Disposal	0.762001	21.6	2.75 Cr	₹137.40	2 L	14 Nov 2024	Market Sale	56,68,060	Insider Trading	—	Equity Shares
17 Nov 2024	Promoter Group	Disposal	0.43969	2.63	1.59 Cr	₹137.40	1.15 L	14 Nov 2024	Market Sale	6,90,143	Insider Trading	—	Equity Shares
17 Nov 2024	Promoter	Disposal	1.504993	22.36	5.39 Cr	₹136.40	3.95 L	14 Nov 2024	Market Sale	58,68,060	Insider Trading	—	Equity Shares
17 Nov 2024	Promoter Group	Disposal	1.828801	2.77	6.60 Cr	₹137.40	4.80 L	14 Nov 2024	Market Sale	7,26,490	Insider Trading	—	Equity Shares
31 Aug 2023	Promoter Group	Acquisition	0.017899	0.15	3.52 L	₹75	4.70 K	30 Aug 2023	Public Right	40,678	Insider Trading	—	Equity Shares
31 Aug 2023	Promoter Group	Acquisition	0.270396	4.6	7.10 L	₹10	70.97 K	30 Aug 2023	Public Right	12,06,490	Insider Trading	—	Equity Shares